Tealwood Asset Management Inc Innoviva, Inc. Transaction History

Tealwood Asset Management Inc

5 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2018 Oct 16, 2018	SELL	$13.63 - $15.7 $2.69 Million - $3.1 Million	-197,483 Closed	0 $0
Q2 2018 Jul 25, 2018	BUY	$13.44 - $17.59 $3,830 - $5,013	285 Added 0.14%	197,483 $2.73 Million
Q1 2018 Apr 20, 2018	BUY	$13.8 - $16.99 $35,397 - $43,579	2,565 Added 1.32%	197,198 $3.29 Million
Q4 2017 Jan 19, 2018	BUY	$11.73 - $14.75 $49,887 - $62,731	4,253 Added 2.23%	194,633 $2.76 Million
Q3 2017 Oct 12, 2017	BUY	$12.06 - $14.12 $2.3 Million - $2.69 Million	190,380	190,380 $2.69 Million

229

79.2M

37.6K

300

Ticker INVA
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 69,706,000
Market Cap $1.33B
Description
Innoviva, Inc. engages in the development and commercialization of pharmaceuticals in the United States and internationally. Its products include RELVAR/BREO ELLIPTA, a once-daily combination medicine consisting of a LABA, vilanterol (VI), an inhaled corticosteroid (ICS), and fluticasone furoate; ANORO ELLIPTA, a once-daily medicine combining a ...

Get notified when there are updates to the investment portfolio of Tealwood Asset Management Inc, based on Form 13F filings with the SEC.

Stay updated on Tealwood Asset Management Inc with notifications on news.